DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 33 · September 2000 DOI: 10.1055/s-002-479

Original Paper

165
Marazziti, D.; Muratori, F.; Cesari, A.; Masala, I.; Baroni, S.; Giannaccini, G.; Dell'Osso, L.; Cosenza, A.; Pfanner, P.; Cassano, G. B.: Increased Density of the Platelet Serotonin Transporter in Autism
174
Bandelow, B.; Broocks, A.; Pekrun, G.; George, A.; Meyer, T.; Pralle, L.; Bartmann, U.; Hillmer-Vogel, U.; Rüther, E.: The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
182
Winterer, G.; Hermann, W. M.: Valproate and the symptomatic treatment of schizophrenia spectrum patients
189
Sattler, H.-D.; Richter, P.; Fritzsche, M.; von Turner, A.; Barnett, W.: Neurophysiologic Tests during Antidepressive Treatment - an Exploratory Study
189
Hikichi, T.; Akiyoshi, J.; Yamamoto, Y.; Tsutsumi, T.; Isogawa, K.; H, Nagayama: Suppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526

Case Report

194
Stadtland, C.; Erfurth, A.; Arolt, V.: De Novo Onset of Parkinson's Disease After Antidepressant Treatment With Citalopram